| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 331 | 312 | - | 1.225 | 6.891 | 9.090 | 8.369 | 8.045 | 6.855 | 11.844 |
| Total Income - EUR | 6.180 | 312 | - | 1.225 | 6.891 | 9.090 | 8.369 | 8.045 | 6.855 | 11.844 |
| Total Expenses - EUR | 40.470 | 0 | - | 59 | 334 | 350 | 411 | 243 | 443 | 7.064 |
| Gross Profit/Loss - EUR | -34.290 | 312 | - | 1.166 | 6.557 | 8.740 | 7.958 | 7.802 | 6.413 | 4.780 |
| Net Profit/Loss - EUR | -34.475 | 302 | - | 1.129 | 6.350 | 8.491 | 7.707 | 7.560 | 5.361 | 3.856 |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Med-Terapy Naturaly S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 337 | 2.944 | - | 236 | 169 | 165 | 162 | 162 | 0 | 0 |
| Current Assets | 5.072 | 7.113 | - | 284 | 15 | 0 | 0 | 0 | 634 | 4.359 |
| Inventories | 1.519 | 1.504 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.087 | 3.847 | - | 0 | 0 | 0 | 0 | 0 | 0 | 437 |
| Cash | 1.466 | 1.762 | - | 284 | 15 | 0 | 0 | 0 | 634 | 3.922 |
| Shareholders Funds | -48.481 | -45.073 | - | -44.410 | -37.200 | -28.004 | -19.676 | -12.176 | -6.779 | -2.884 |
| Social Capital | 56 | 56 | - | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 53.889 | 55.130 | - | 44.930 | 37.383 | 28.169 | 19.837 | 12.339 | 7.413 | 7.243 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Med-Terapy Naturaly S.r.l.